Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LBX Pharmacy Chain JSCSHSE:603883 -3.00%80 PS Ratio is 0.41 as of Jul. 26, 2026, which is 69% below its 10-year median of 1.33. GuruFocus rates SHSE:603883 with a GF Score™ of 80/100 and a GF Value™ of ¥19.26 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 658 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks better than 83.89% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, LBX Pharmacy Chain JSC's share price is ¥11.97.
LBX Pharmacy Chain JSC's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥29.21. Hence, LBX Pharmacy Chain JSC's PS Ratio for today is 0.41.
Good Sign:
LBX Pharmacy Chain JSC stock PS Ratio (=0.41) is close to 10-year low of 0.38.
The historical rank and industry rank for LBX Pharmacy Chain JSC's PS Ratio or its related term are showing as below:
SHSE:603883'
s PS Ratio Range Over the Past 10 Years
Min: 0.38 Med: 1.33 Max: 2.84
Current: 0.41
During the past 13 years, LBX Pharmacy Chain JSC's highest PS Ratio was 2.84. The lowest was 0.38. And the median was 1.33.
SHSE:603883's PS Ratio is ranked better than 83.89% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 1.465
vs SHSE:603883: 0.41
LBX Pharmacy Chain JSC revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of LBX Pharmacy Chain JSC was 0.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 14.90% per year.
During the past 13 years, LBX Pharmacy Chain JSC's highest 3-Year average Revenue per Share Growth Rate was 21.40% per year. The lowest was 2.70% per year. And the median was 15.00% per year.
Back to Basics: PS Ratio
LBX Pharmacy Chain JSC (SHSE:603883) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBX Pharmacy Chain JSC PS Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's PS Ratio distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
LBX Pharmacy Chain JSC's Share Price of today is ¥11.97. LBX Pharmacy Chain JSC's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥29.21.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
LBX Pharmacy Chain JSC (SHSE:603883) has a PS Ratio of 0.41 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on LBX Pharmacy Chain JSC and its competitors. This is 69% below median its historical median of 1.33. Over the past decade, LBX Pharmacy Chain JSC's PS Ratio has ranged from 0.38 to 2.84. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #106 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is LBX Pharmacy Chain JSC's PS Ratio too high?
LBX Pharmacy Chain JSC's current PS Ratio of 0.41 is 69% below median its 10-year median of 1.33. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 2.84. The Healthcare Providers & Services industry median PS Ratio is 1.47. LBX Pharmacy Chain JSC's value of 0.41 is 72% below this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #106 out of 658 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #106 out of 658 companies for PS Ratio. This places LBX Pharmacy Chain JSC in the top 16% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.47. LBX Pharmacy Chain JSC's value of 0.41 is 72% below this benchmark. Historically, LBX Pharmacy Chain JSC's own PS Ratio has ranged from 0.38 to 2.84 over the past decade. While the company's 10-year median is 1.33 vs. the industry median of 1.47, LBX Pharmacy Chain JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current PS Ratio of 0.41 is 72% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current PS Ratio is 0.41, which is 69% below median its own 10-year median of 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.26, compared to a current price of ¥11.97 — trading 37.9% below its estimated fair value. The current PS Ratio is 0.41, which is 69% below median its 10-year median of 1.33 and 72% below the Healthcare Providers & Services industry median of 1.47. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current PS Ratio is 0.41 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥11.97 is trading 37.9% below its estimated GF Value™ of ¥19.26.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
PS Ratio: 0.41 (69% below median its 10-year median of 1.33)
GF Value™: ¥19.26 vs. price of ¥11.97 (37.9% below fair value)
Industry Position: 72% below the Healthcare Providers & Services median (#106 of 658)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score
Get the complete analysis for SHSE:603883
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
